Multi-omics therapeutic perspective on ACVR1 gene: from genetic alterations to potential targeting
Briefings in Functional Genomics · 2023
DOI: 10.1093/bfgp/elac026 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Briefings in Functional Genomics, 2023. Verfasst von Garima Nagar und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Myositis Ossificans. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 137 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Activin A receptor type I (ACVR1), a transmembrane serine/threonine kinase, belongs to the transforming growth factor-β superfamily, which signals via phosphorylating the downstream effectors and SMAD transcription factors. Its central role in several biological processes and intracellular signaling is well known. Genetic variation in ACVR1 has been associated with a rare disease, fibrodysplasia ossificans progressive, and its somatic alteration is reported in rare cancer diffuse intrinsic pontine glioma. Furthermore, altered expression or variation of ACVR1 is associated with multiple pathologies such as polycystic ovary syndrome, congenital heart defects, diffuse idiopathic skeletal hyperostosis, posterior fossa ependymoma and other malignancies. Recent advancements have witnessed ACVR1 as a potential pharmacological target, and divergent promising approaches for its therapeutic targeting have been explored. This review highlights the structural and functional characteristics of receptor ACVR1, associated signaling pathways, genetic variants in several diseases and cancers, protein–protein interaction, gene expression, regulatory miRNA prediction and potential therapeutic targeting approaches. The comprehensive knowledge will offer new horizons and insights into future strategies harnessing its therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
ORCID-Profile: Indrakant Kumar Singh
Förderung
- Indian Council of Medical Research
Zitieren
APA
Nagar, G., Mittal, P., Gupta, S. R. R., Pahuja, M., Sanger, M., Mishra, R., Singh, A., & Singh, I. K. (2023). Multi-omics therapeutic perspective on ACVR1 gene: from genetic alterations to potential targeting. Briefings in Functional Genomics. https://doi.org/10.1093/bfgp/elac026
Vancouver
Nagar G, Mittal P, Gupta SRR, Pahuja M, Sanger M, Mishra R, et al. Multi-omics therapeutic perspective on ACVR1 gene: from genetic alterations to potential targeting. Briefings in Functional Genomics. 2023. doi:10.1093/bfgp/elac026
BibTeX
@article{Nagar2023,
author = {Nagar, Garima and Mittal, Pooja and Gupta, Shradheya R R and Pahuja, Monika and Sanger, Manisha and Mishra, Ruby and Singh, Archana and Singh, Indrakant Kumar},
title = {Multi-omics therapeutic perspective on ACVR1 gene: from genetic alterations to potential targeting},
journal = {Briefings in Functional Genomics},
year = {2023},
doi = {10.1093/bfgp/elac026}
}
EUVIMED